RN-5681

N/A

Report date: 2026/04/04 20:00:24

Base Information

Drug NameRN-5681
Drug Alias NameRN-5681RN5681
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 modulatorsApolipoprotein(a) modulators
TargetsProprotein convertase subtilisin kexin type 9Apolipoprotein(a)
Therapy Area/IndicationsHypercholesterolemiaAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesRona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDarui Biomedical Technology (Shanghai) Co LtdIkaria Bioscience Pty LtdRona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A